Follicular lymphoma subgrouping by fluorescence in situ hybridization analysis.
The frequency of t(14;18) in follicular lymphoma (FL) in Japan has been reported to be low compared to North America and other European countries. Recently, it has also been reported that FL lacks t(14;18), mainly among histological grade 3b, and occasionally has a rearranged Bcl-6 gene. It is not known whether a difference in histology or immunostaining pattern exists between FL with and without t(14;18). We performed interphase fluorescence in situ hybridization (FISH) analysis to detect Bcl-2/IgH, Bcl-6 gene rearrangement, Bcl-2 gene amplification, and the cyclinD1/IgH gene in formalin-fixed paraffin embedded specimens from our FL archives. The correlation between morphological features, histological grades, immunohistochemical findings, and cytogenetical aberrations was studied. In total, we found that 28 of 47 cases (59.6%) had t(14;18). Bcl-6 gene rearrangement and extra Bcl-2 gene signals were found in five and two cases, respectively. Only one had cyclinD1/IgH fusion. Ten of 12 grade 1, nine of 17 grade 2, and 0 of two grade 3 cases had fusion signals, respectively. None of the above abnormalities were detected in 12 of 47 cases (25.5%). Our data confirmed a high frequency of t(14;18) in FL in grade 1, but a lower incidence among grade 2, that could be attributed to the lower incidence of the translocation in FL in Japan. Immunostaining of both Bcl-2 and CD10 was highly predictable for the presence of t(14;18); the positive predictive value was 75%, suggesting the usefulness of the staining.
Sekiguchi
Naohiro
N
Hematology Division, National Cancer Center Hospital, Tokyo, Japan.
Kobayashi
Yukio
Y
Yokota
Yukiko
Y
Kusumoto
Shigeru
S
Tanimoto
Kazuki
K
Watanabe
Takashi
T
Matsuno
Yoshihiro
Y
Tobinai
Kensei
K
D000328:Adult; D000368:Aged; D002883:Chromosomes, Human, Pair 14; D002887:Chromosomes, Human, Pair 18; D005260:Female; D015321:Gene Rearrangement; D019254:Genes, bcl-2; D006801:Humans; D007143:Immunoglobulin Heavy Chains / Q000032:analysis; D007150:Immunohistochemistry; D017404:In Situ Hybridization, Fluorescence; D008224:Lymphoma, Follicular / Q000235:genetics* / Q000378:metabolism / Q000473:pathology; D008297:Male; D008875:Middle Aged; D014178:Translocation, Genetic
D007143:Immunoglobulin Heavy Chains
Histopathology. 1988 Jun;12(6):649-58
3047044
Br J Haematol. 2003 Feb;120(3):424-33
12580956
Ann Oncol. 1998 Jul;9(7):717-20
9739436
Blood. 2003 Feb 1;101(3):1149-54
12529293
J Clin Oncol. 1999 Dec;17(12):3835-49
10577857
Leukemia. 2003 Jan;17(1):255-9
12529690
Blood. 2002 May 15;99(10):3806-12
11986240
Cancer Cell. 2003 Feb;3(2):185-97
12620412
Cancer Genet Cytogenet. 2004 Apr 1;150(1):22-6
15041219
Jpn J Cancer Res. 1993 Jan;84(1):37-41
8449825
Leukemia. 2002 Nov;16(11):2309-17
12399977
Blood. 1989 Feb 15;73(3):787-91
2644990
Blood. 2002 Jun 15;99(12):4265-75
12036852
Leukemia. 1996 Jun;10(6):970-7
8667654
Mol Pathol. 1999 Dec;52(6):357-9
10748871
Pathol Int. 2000 Sep;50(9):696-702
11012982
Int J Hematol. 2002 Nov;76(4):333-7
12463596
J Clin Oncol. 1998 Aug;16(8):2780-95
9704731
Blood. 1997 Jun 1;89(11):3909-18
9166827
Jpn J Clin Oncol. 1996 Dec;26(6):445-54
9001350